Literature DB >> 14687884

NMDA receptor-mediated immediate Ser831 phosphorylation of GluR1 through CaMKIIalpha in rat hippocampus during early global ischemia.

Xin-Zhen Fu1, Quan-Guang Zhang, Fan-Jie Meng, Guang-Yi Zhang.   

Abstract

The phosphorylation of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors subunit GluR1 at Ser831 has been implicated in the regulation of AMPA receptors channel. In this paper, Ser831 phosphorylation of GluR1 in rat hippocampus was investigated, which significantly increased during early global ischemia. To further illustrate the underlying mechanisms, calcium/calmodulin-dependent kinase IIalpha (CaMKIIalpha) inhibitor 1-[N,O-bis-(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine (KN62), CaM antagonist trifluoperazine (TFP), N-methyl-D-aspartate (NMDA) receptor antagonist dextromethorphan (DEX), AMPA receptor antagonist 6,7-dinitro-quinoxaline-2,3-(1H,4H)-dione (DNQX) and L-type voltage-gated Ca2+ channel (L-VGCC) blocker nifedipine (NIF), were respectively administrated to the rats 20 min prior to ischemia. The results showed that KN62, TFP and DEX significantly attenuated Ser831 phosphorylation of GluR1, while DNQX and NIF had no obvious effects. Consequently, the studies suggest that early global ischemia induced Ser831 phosphorylation of GluR1 may be closely associated with CaMKIIalpha and the NMDA receptor, while the immediate Ser831 phosphorylation of GluR1 may have been involved in pathogenic events after early global ischemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14687884     DOI: 10.1016/j.neures.2003.09.009

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  8 in total

Review 1.  Phosphorylation of AMPA receptors: mechanisms and synaptic plasticity.

Authors:  John Q Wang; Anish Arora; Lu Yang; Nikhil K Parelkar; Guochi Zhang; Xianyu Liu; Eun Sang Choe; Limin Mao
Journal:  Mol Neurobiol       Date:  2005-12       Impact factor: 5.590

2.  NMDA receptor mediated phosphorylation of GluR1 subunits contributes to the appearance of calcium-permeable AMPA receptors after mechanical stretch injury.

Authors:  Jennifer Spaethling; Linda Le; David F Meaney
Journal:  Neurobiol Dis       Date:  2012-03-09       Impact factor: 5.996

3.  Ca2+/calmodulin-dependent protein kinase II inhibitors disrupt AKAP79-dependent PKC signaling to GluA1 AMPA receptors.

Authors:  Ian M Brooks; Steven J Tavalin
Journal:  J Biol Chem       Date:  2010-12-14       Impact factor: 5.157

4.  The Zinc Ion Chelating Agent TPEN Attenuates Neuronal Death/apoptosis Caused by Hypoxia/ischemia Via Mediating the Pathophysiological Cascade Including Excitotoxicity, Oxidative Stress, and Inflammation.

Authors:  Wei-Ming Wang; Zhao Liu; Ai-Jun Liu; Yu-Xiang Wang; Hong-Gang Wang; Di An; Bin Heng; Lai-Hua Xie; Jun-Li Duan; Yan-Qiang Liu
Journal:  CNS Neurosci Ther       Date:  2015-07-20       Impact factor: 5.243

5.  The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior.

Authors:  Jing Du; Thomas K Creson; Long-Jun Wu; Ming Ren; Neil A Gray; Cynthia Falke; Yanling Wei; Yun Wang; Rayah Blumenthal; Rodrigo Machado-Vieira; Peixiong Yuan; Guang Chen; Min Zhuo; Husseini K Manji
Journal:  J Neurosci       Date:  2008-01-02       Impact factor: 6.167

6.  Spatial memory deficits and motor coordination facilitation in cGMP-dependent protein kinase type II-deficient mice.

Authors:  Charlotte M Wincott; Seonil Kim; Roseann F Titcombe; David S Tukey; Hiwot K Girma; Joseph E Pick; Loren M Devito; Franz Hofmann; Charles Hoeffer; Edward B Ziff
Journal:  Neurobiol Learn Mem       Date:  2012-10-24       Impact factor: 2.877

Review 7.  The molecular pharmacology and cell biology of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.

Authors:  Claire L Palmer; Lucy Cotton; Jeremy M Henley
Journal:  Pharmacol Rev       Date:  2005-06       Impact factor: 25.468

8.  Xenon prevents cellular damage in differentiated PC-12 cells exposed to hypoxia.

Authors:  Christian Petzelt; Per Blom; Wolfgang Schmehl; Jana Müller; Wolfgang J Kox
Journal:  BMC Neurosci       Date:  2004-12-08       Impact factor: 3.288

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.